The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
On July 31, President Trump sent letters to some of the largest pharmaceutical companies in the world (AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, and Sanofi) asking them to fundamentally change drug pricing in the US. What was…
Richard Clarke, Ph.D., Highmark’s chief analytics officer, says AI solution will help clinicians understand in real-time whether they have inadequate evidence for a prior authorization
To prevent further harm and ensure families aren’t left behind again, we must use data more proactively — not only to close gaps in coverage but also to support accountability in how care continuity is managed. The post Can Data Help Build Healthcare’s Equitable Future? appeared first on MedCity News.
[Sponsored] Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S. The post Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies appeared first on MedCity News.
As healthcare continues to become more and more dependent on third-party vendor services, provider and technology entities must remain focused on the risks that their vendors present. The post “Here, There and Everywhere”: Vendor Risks in the Health Care Sector appeared first on MedCity News.
This volume analyzes findings from the latest KFF Tracking Poll on Health Information and Trust, which show that just over half of adults say they use social media to find health information and advice, but less than half trust the health content they see across an array of social media sites and apps. It also…
This volume analyzes findings from the latest KFF Tracking Poll on Health Information and Trust, which show that just over half of adults say they use social media to find health information and advice, but less than half trust the health content they see across an array of social media sites and apps. It also…
[Sponsored] The 2025 Benefits Sentiment Index, a survey of 120 benefit consultants to self-insured employers, focuses on healthcare navigation, GLP-1 drug coverage and AI trends for healthcare benefits. The post Healthcare Benefit Trends Report: Managers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions appeared first on MedCity News.